Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
Lucia Scisciola(University of Campania "Luigi Vanvitelli"), Michelangela Barbieri(University of Campania "Luigi Vanvitelli")
Cited by 48
Related Papers
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients
|Frontiers in Physiology|2018|61
Tirzepatide prevents neurodegeneration through multiple molecular pathways
|Journal of Translational Medicine|2024|58
Vinorelbine and Paclitaxel as First-Line Chemotherapy in Metastatic Breast Cancer
|Journal of Clinical Oncology|1999|54
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line
|Frontiers in Pharmacology|2022|9